CAR-T Therapy Improved with Immunity-Boosting Protein, IL-7
For over 30 years, researchers have explored T-cell engineering as a potential cure for cancer. Their advances have changed the course of treatment for many types of blood cancers, including lymphoma, certain types of leukemia, and multiple myeloma. Upon seeing the power of CAR-T therapy treatments, researchers have collectively set out to push the science […]
Continue Reading